JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB7153

Goat Anti-Human IgG H&L (HRP) preadsorbed

Be the first to review this product! Submit a review

|

(6 Publications)

Suitable for WB, Dot, IHC-P, ELISA. Ideal for western blot. Preadsorbed to minimise non-specific binding and high background staining. Cited in 6 publications.

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1

Key facts

Host species

Goat

Target species

Human

Target isotype

IgG

Target specificity

Heavy & Light chains

Minimal cross-reactivity

Mouse, Rat, Sheep, Rabbit, Goat, Horse, Chicken, Guinea pig, Hamster, Cow,

Pre-adsorbed

Yes

Conjugation

HRP

Excitation/Emission
Applications

ELISA, WB, IHC-P, Dot

applications

Clonality

Polyclonal

Isotype

IgG

Immunogen

Native Full Length Protein corresponding to Human IGHG1.

P01857

Specificity

No reaction was observed against Bovine, Chicken, Goat, Guinea Pig, Hamster, Horse, Mouse, Rabbit, Rat and Sheep Serum Proteins.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/1000 - 1/5000", "notes":"<p></p>" }, "Dot": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/500 - 1/2500", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/200000", "notes":"<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification
Purification notes
This product was prepared from monospecific antiserum by immunoaffinity chromatography using human IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities.
Storage buffer
Preservative: 0.01% Gentamicin sulphate Constituents: 1% BSA, 0.88% Sodium chloride, 0.424% Potassium phosphate solution
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

Target data

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells.
See full target information IGHG1

Additional targets

IGHG4,IGHG2,IGHG3

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Nature biotechnology 43:960-970 PubMed39143416

2024

Rapid discovery of monoclonal antibodies by microfluidics-enabled FACS of single pathogen-specific antibody-secreting cells.

Applications

Unspecified application

Species

Unspecified reactive species

Katrin Fischer,Aleksei Lulla,Tsz Y So,Pehuén Pereyra-Gerber,Matthew I J Raybould,Timo N Kohler,Juan Carlos Yam-Puc,Tomasz S Kaminski,Robert Hughes,Gwendolyn L Pyeatt,Florian Leiss-Maier,Paul Brear,Nicholas J Matheson,Charlotte M Deane,Marko Hyvönen,James E D Thaventhiran,Florian Hollfelder

Nature chemical biology 18:1270-1276 PubMed36076082

2022

Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors.

Applications

Unspecified application

Species

Unspecified reactive species

Payton A-B Weidenbacher,Eric Waltari,Izumi de Los Rios Kobara,Benjamin N Bell,Mary Kate Morris,Ya-Chen Cheng,Carl Hanson,John E Pak,Peter S Kim

Cancer cell international 22:42 PubMed35090460

2022

miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Hu Han,Yan Li,Wan Qin,Lu Wang,Han Yin,Beibei Su,Xianglin Yuan

Protein science : a publication of the Protein Society 30:716-727 PubMed33586288

2021

Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library.

Applications

Unspecified application

Species

Unspecified reactive species

Benjamin N Bell,Abigail E Powell,Carlos Rodriguez,Jennifer R Cochran,Peter S Kim

Journal of controlled release : official journal of the Controlled Release Society 317:130-141 PubMed31756392

2019

Temporal release of a three-component protein subunit vaccine from polymer multilayers.

Applications

Unspecified application

Species

Unspecified reactive species

Divakara S S M Uppu,Michelle E Turvey,Abdul Rahim Mohammed Sharif,Katell Bidet,Yanpu He,Victor Ho,Anagha D Tambe,Julien Lescar,Ern Yu Tan,Katja Fink,Jianzhu Chen,Paula T Hammond

Arteriosclerosis, thrombosis, and vascular biology 39:1884-1892 PubMed31315438

2019

Association Between ApoA-I (Apolipoprotein A-I) Immune Complexes and Adverse Cardiovascular Events-Brief Report.

Applications

Unspecified application

Species

Unspecified reactive species

David Henson,Ayman Samman Tahhan,David Nardo,Arshed Ali Quyyumi,Vincent J Venditto
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com